1. Market Research
  2. > Business Services
  3. > Advertising and Marketing Market Trends
  4. > Physician Views – How do European cardiologists perceive oral anticoagulants versus warfarin? – Is Eliquis, Pradaxa or Xarelto their favoured option?

Scope

Sales forecasts for Bristol-Myers Squibb and Pfizer's anticoagulant product Eliquis have declined notably in recent months. According to Bloomberg, current consensus estimates suggest 2018 global revenues of $2.3 billion. This compares to a previous estimate of $3.8 billion as recently as April and expectations of over $5 billion last year prior to the drug gaining full regulatory approval.

On paper, Eliquis has the strongest clinical profile among the new generation of oral anticoagulants, argue numerous analysts and key opinion leaders (KOLs), however, this has yet to translate into commercial performance since launch. Furthermore, Bayer and Johnson & Johnson's Xarelto has continued to see its revenue performance improve robustly in recent quarters, adding further pressure on expectations for Eliquis.

When FirstWord polled US-based cardiologists in June about their usage of Eliquis, feedback suggested that superiority over Xarelto and Boehringer Ingelheim's Pradaxa was not a widely held view FirstWord Pharma PLUS subscribers can view the results and analysis from this poll here.

This may change as experience with the product increases, while both Bristol-Myers Squibb and Pfizer have argued that formulary positioning – which they expect to improve over the remainder of 2013 – and direct-to-consumer (DTC) advertising should drive an inflection in sales for Eliquis.

In Europe, the market for next-generation oral anticoagulants continues to expand robustly, noted analysts at Barclay's recently, but Eliquis – against their expectations – is failing to assume the levels of market share anticipated. This could benefit Xarelto significantly, they suggest, given that the market for these products is expected to double over the next 12 months.

Reasons to Buy this Report

This week's FirstWord Physician Views poll will ask:
• How do the clinical profiles of oral anticoagulants compare with warfarin?
• How does the clinical profile of Eliquis compare to other oral anticoagulants?
• Which product – Eliquis, Pradaxa or Xarelto – is their favoured treatment option?
• For what reason did they select that product?
• In what percentage of atrial fibrillation patients do they expect to be prescribing Eliquis to in 18 month's time?

Table Of Contents

Physician Views - How do European cardiologists perceive oral anticoagulants versus warfarin? - Is Eliquis, Pradaxa or Xarelto their favoured option?

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Free-to-air Service Market - Europe and Middle East & Africa Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Free-to-air Service Market - Europe and Middle East & Africa Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

EMEA Free-to-air Service Market: Overview Free-to-air service refers to audio and audio-visual content broadcasted free of cost to radio sets and television sets. This implies that the unencrypted form ...

Ingredient Authentication Testing Solutions Market: By Technology (Polymerase Chain Reaction, Chromatography, Spectroscopy); By Source (Plant Derived, Animal Derived); By Industry (Military, Medical and others) & By Region-Forecast (2016-2022)

Ingredient Authentication Testing Solutions Market: By Technology (Polymerase Chain Reaction, Chromatography, Spectroscopy); By Source (Plant Derived, Animal Derived); By Industry (Military, Medical and others) & By Region-Forecast (2016-2022)

  • $ 5347
  • Industry report
  • September 2016
  • by Industry ARC

Ingredient authentication testing solutions can be defined as kits and products used by various agencies and governing bodies to authenticate the ingredients displayed by manufacturers and check for any ...

Global Market Study on Hearing Aids: Digital Hearing Aids Technology Segment Anticipated to Register 3.9% CAGR Between 2016 and 2024

Global Market Study on Hearing Aids: Digital Hearing Aids Technology Segment Anticipated to Register 3.9% CAGR Between 2016 and 2024

  • $ 4900
  • Industry report
  • November 2016
  • by Persistence Market Research

A new report by Persistence Market Research examines the global hearing aids market during the period 2016–2024. The primary objective of the report is to offer updates and information related to market ...

Global Yellow Pages - Services

November 2016 $ 4500

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.